A carregar...
A case of remarkable response to atezolizumab in ALK-translocated metastatic lung adenocarcinoma
The development of resistance to tyrosine kinase inhibitors (TKIs) in metastatic non-small cell lung cancer (NSCLC) with oncogenic driver mutations highlights the challenge in improving the survival of these patients. The standard of care for ALK-rearranged advanced NSCLC refractory to various gener...
Na minha lista:
| Publicado no: | Respir Med Case Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8318922/ https://ncbi.nlm.nih.gov/pubmed/34336591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2021.101478 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|